Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Knick

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Molecular Cancer Therapeutics|February 3, 2007
In vitro biological activity of a novel small-molecule inhibitor of polo-like kinase 1Timothy J Lansing, Randy T McConnell, Derek R Duckett, et al.
Bioorganic & Medicinal Chemistry Letters|July 2, 2005
Discovery of a novel and potent series of dianilinopyrimidineurea and urea isostere inhibitors of VEGFR2 tyrosine kinaseDouglas M Sammond, Kristen E Nailor, James M Veal, et al.
Bioorganic & Medicinal Chemistry Letters|October 7, 2008
Synthesis and evaluation of pyrazolo[1,5-b]pyridazines as selective cyclin dependent kinase inhibitorsKirk L Stevens, Michael J Reno, Jennifer B Alberti, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2009
2,3,5-Trisubstituted pyridines as selective AKT inhibitors-Part I: Substitution at 2-position of the core pyridine for ROCK1 selectivityHong Lin, Dennis S Yamashita, Jin Zeng, et al.
Molecular Cancer Therapeutics|July 11, 2007
Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activityRakesh Kumar, Victoria B Knick, Sharon K Rudolph, et al.
Bioorganic & Medicinal Chemistry Letters|December 23, 2008
Discovery of thiophene inhibitors of polo-like kinaseKyle A Emmitte, C Webb Andrews, Jennifer G Badiang, et al.
Journal of Medicinal Chemistry|July 16, 2008
Discovery of 5-[[4-[(2,3-dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-benzenesulfonamide (Pazopanib), a novel and potent vascular endothelial growth factor receptor inhibitorPhilip A Harris, Amogh Boloor, Mui Cheung, et al.
Cancer Research|April 3, 2008
Characterization of an Akt kinase inhibitor with potent pharmacodynamic and antitumor activityNelson Rhodes, Dirk A Heerding, Derek R Duckett, et al.
Science (New York, N.Y.)|January 6, 2001
Prevention of chemotherapy-induced alopecia in rats by CDK inhibitorsS T Davis, B G Benson, H N Bramson, et al.
Science (New York, N.Y.)|January 16, 2003
RetractionStephen T Davis, Bill G Benson, H Neal Bramson, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Molecular Cancer Therapeutics|February 3, 2007
In vitro biological activity of a novel small-molecule inhibitor of polo-like kinase 1Timothy J Lansing, Randy T McConnell, Derek R Duckett, et al.
Bioorganic & Medicinal Chemistry Letters|July 2, 2005
Discovery of a novel and potent series of dianilinopyrimidineurea and urea isostere inhibitors of VEGFR2 tyrosine kinaseDouglas M Sammond, Kristen E Nailor, James M Veal, et al.
Bioorganic & Medicinal Chemistry Letters|October 7, 2008
Synthesis and evaluation of pyrazolo[1,5-b]pyridazines as selective cyclin dependent kinase inhibitorsKirk L Stevens, Michael J Reno, Jennifer B Alberti, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2009
2,3,5-Trisubstituted pyridines as selective AKT inhibitors-Part I: Substitution at 2-position of the core pyridine for ROCK1 selectivityHong Lin, Dennis S Yamashita, Jin Zeng, et al.
Molecular Cancer Therapeutics|July 11, 2007
Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activityRakesh Kumar, Victoria B Knick, Sharon K Rudolph, et al.
Bioorganic & Medicinal Chemistry Letters|December 23, 2008
Discovery of thiophene inhibitors of polo-like kinaseKyle A Emmitte, C Webb Andrews, Jennifer G Badiang, et al.
Journal of Medicinal Chemistry|July 16, 2008
Discovery of 5-[[4-[(2,3-dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-benzenesulfonamide (Pazopanib), a novel and potent vascular endothelial growth factor receptor inhibitorPhilip A Harris, Amogh Boloor, Mui Cheung, et al.
Cancer Research|April 3, 2008
Characterization of an Akt kinase inhibitor with potent pharmacodynamic and antitumor activityNelson Rhodes, Dirk A Heerding, Derek R Duckett, et al.
Science (New York, N.Y.)|January 6, 2001
Prevention of chemotherapy-induced alopecia in rats by CDK inhibitorsS T Davis, B G Benson, H N Bramson, et al.
Science (New York, N.Y.)|January 16, 2003
RetractionStephen T Davis, Bill G Benson, H Neal Bramson, et al.
Pageof 7